Abstract
Sleep disturbances and problems are increased in ankylosing spondylitis (AS). But much is not known in a quantitative way about sleep problems and effect of treatments on AS. This study is aimed first, to investigate sleep disturbances in AS and secondly, to evaluate the effects of anti-TNF treatment on SD in AS. One hundred seventy-one (Female/male: 90/81) AS patients fulfilling modified New York criteria and 86 (F/M: 56/30) age- and gender-matched controls without inflammatory diseases were included into the study. Demographic data and disease activity and treatments were recorded using The Bath Ankylosing Spondylitis Functional Index (BASFI) and The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The Medical Outcomes Study (MOS) Sleep Questionnaire was used for evaluating sleep and problems of sleep. AS patients had higher sleep disturbance scale (SDS) and sleep problem index (SPI) II scores. Group A (patients using NSAID and/or DMARD, 53.2% of patients) had higher BASDAI and BASFI compared with Group B (Patients using anti-TNF treatments) (4.29 ± 2.38 vs. 2.46 ± 2.32, p < 0.001; 1.95 ± 2.15 vs. 0.93 ± 1.31, p < 0.001, respectively). Whereas Group A had higher scores of SDS, awaken short of breath or headache, somnolence, and SPI-II than controls, none of the sleep parameters were statistically different between patients on anti-TNF treatments and controls. BASDAI was positively correlated with SPI-I, SPI-II, SDS, and somnolence scale. AS patients had increased sleep problems and disturbances compared with controls. Anti-TNF agents improve significantly these problems. Sleep problems are significantly correlated with the disease activity.
Similar content being viewed by others
References
Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255
Abad VC, Sarinas PSA, Guilleminault G (2008) Sleep and rheumatologic disorders. Sleep Med Reviews 12:211–228
Calin A, Edmunds L, Kennedy LG (1993) Fatigue in ankylosing spondylitis–why is it ignored? J Rheumatol 20:991–995
Hultgren S, Broman JE, Gudbjörnsson B, Hetta J, Lindqvist U (2000) Sleep disturbances in outpatients with ankylosing spondylitis- a questionnaire study with gender implications. Scand J Rheumatol 29(6):365–369
Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H et al (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499–505
Davis JC Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO et al (2003) For the enbrel ankylosing spondylitis study group. recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48:3230–3236
Van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J et al (2006) For the ATLAS study group efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54:2136–2146
Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
Karatepe AG, Akkoc Y, Akar S et al (2005) The turkish versions of the bath ankylosing spondylitis and dougados functional indices: reliability and validity. Rheumatol Int 25:612–618
Akkoc Y, Karatepe AG, Akar S et al (2005) A turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284
Hays R, Stewart A (1992) Sleep measures. In: Stewart A, Ware J (eds) Measuring functioning and well-being approach: the medical outcomes study. Duke University Press, Durham, NC, pp 235–259
Wolfe F, Michaud K, Li T (2006) Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomed study and visual analog sleep scales. J Rheumatol 33:1942–1951
Gunaydin R, Karatepe AG, Cesmeli N, Kaya T (2009) Fatigue in patients with ankylosng spondylitis: relationships with disease-specific variables, depression, and sleep disturbances. Clin Rheumatol 28:1045–1051
Inman RD, Davis JC Jr, van der Heijde D et al (2008) Efficacy and safety of golimumab in patients with ankylosing spondylitis. results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 58:3402–3412
Erb N, Karokis D, Delamere JP et al (2003) Obstructive sleep apnoea as a cause of fatigue in ankylosing spondylitis. Ann Rheum Dis 62:183–184
Solak O, Fidan F, Dundar U, Turel A, Aycicek A, Kavuncu V, Unlu M (2009) The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rheumatol (Oxf) 48:433–435
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karadağ, Ö., Nakas, D., Kalyoncu, U. et al. Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int 32, 1909–1913 (2012). https://doi.org/10.1007/s00296-011-1907-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1907-x